| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 05/03/2007 | WO2006038208A3 Agents capable of downregulating an msf-a - dependent hif-1α and use thereof in cancer treatment |
| 05/03/2007 | US20070099240 Pixel arrays |
| 05/03/2007 | US20070099235 Method for designing surfaces |
| 05/03/2007 | CA2627376A1 Immunogenic compositions and methods of use |
| 05/02/2007 | EP1778278A2 Gonadotropin releasing hormone antagonists |
| 05/02/2007 | CN1313146C Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis |
| 05/01/2007 | US7211566 a nonapeptide analog; antiinflammatory, antidiabetic agents, analgesics, antiastmatic agents |
| 05/01/2007 | US7211445 Conjugation of biomolecules using diels-alder cycloaddition |
| 05/01/2007 | US7211409 Standard compound for immunoassay for dioxin and method of immunoassay for dioxin |
| 05/01/2007 | US7211395 Serum albumin conjugate for use in the transfer and delivery of therapeutic agent to target |
| 05/01/2007 | US7211271 Method to improve hydroxyapatite implantation and stimulate bone regeneration |
| 05/01/2007 | US7211256 Administering to mammal polyclonal or monoclonal antibody, wherein polyclonal or monoclonal antibody recognizes an epitope of a protein of 48,000 daltons determined by immunoblot, wherein protein is a surface protein of a merozoite of Plasmodium falciparum |
| 05/01/2007 | CA2120303C Cyclic adhesion inhibitors |
| 04/26/2007 | WO2007046520A1 Method for screening of protein using immobilized puromycin linker |
| 04/26/2007 | US20070092941 PRO1298 polypeptides |
| 04/26/2007 | US20070092534 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 04/26/2007 | US20070092521 producing a glycosylated monoclonal antibody or Fc fusion protein by culturing the cell in the presence of kifunensine ; for targeted killing of cells in a mammal, including therapeutic methods of treating cancers, autoimmune diseases and other diseases |
| 04/25/2007 | EP1776949A2 A porous, molecularly imprinted polymer and a process for the preparation thereof |
| 04/25/2007 | EP1560939A4 Immobilization of biological molecules onto surfaces coated with monolayers |
| 04/25/2007 | EP1196637B1 Peptide acceptor ligation methods |
| 04/25/2007 | CN1951398A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 04/24/2007 | US7208466 Treating pain or inflammation; inhibiting C-fibre neuron activity; hemagglutinins conjugated with protein |
| 04/24/2007 | US7208156 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule |
| 04/24/2007 | CA2215138C Cell growth substrate polymer |
| 04/19/2007 | WO2006104922A3 Compounds and methods for peptide synthesis |
| 04/19/2007 | US20070088104 Temperature regulating gel and article comprising the same |
| 04/19/2007 | CA2624802A1 Latent procytotoxins and uses thereof |
| 04/18/2007 | EP1773866A1 Use of metal complexes |
| 04/18/2007 | EP1773386A2 Vaccine compositions and methods |
| 04/18/2007 | EP1307490B1 Fv- CONSTRUCTS WITH AN INFLUENCEABLE AFFINITY FOR A SUBSTANCE THAT IS TO BE LINKED |
| 04/17/2007 | US7205161 Polymer brushes for immobilizing molecules to a surface or substrate having improved stability |
| 04/12/2007 | WO2007012605A3 Static support bed for purification, separation, detection, modification and/or immobilization of target entities and method using thereof |
| 04/12/2007 | WO2005060683A3 Small peptides for the treatment of alzheimer’s disease and other beta-amyloid protein fibrillogenesis disorders |
| 04/12/2007 | WO2005050171A3 Methods and compositions relating to single reactive center reagents |
| 04/12/2007 | US20070082335 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction |
| 04/11/2007 | EP1771732A2 Taxol immunoassay |
| 04/11/2007 | EP1771198A2 Interferon-alpha polypeptides and conjugates |
| 04/11/2007 | CN1946417A Inhibitors of type 2 vascular endothelial growth factor receptors |
| 04/10/2007 | US7202345 PRO 1384 antibodies |
| 04/10/2007 | US7202343 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 04/10/2007 | US7202092 Activated haptens useful for generating immunogens to HIV protease inhibitors; reacting indinavir sulfate in the presence of hydrogen gas and palladium catalyst to form indinavir M6 |
| 04/10/2007 | US7201903 Method and device for detecting feline immunodeficiency virus |
| 04/10/2007 | CA2148194C Cyclopeptides of the formula i |
| 04/05/2007 | US20070077651 Cell culture vessel having a polymer surface, a cell adhesion resistant material (CAR) bonded to the polymer (e.g., hyaluronic acid), and one or more peptides covalently bound to the CAR material that promote adherence of cells that do not adhere to the CAR layer in the absence of the peptides |
| 04/04/2007 | CN1942199A Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes |
| 04/03/2007 | US7199100 Oligopeptides; antitumor agents, antiinflammatory agents, antiischemic agents, vision defects |
| 04/03/2007 | US7198958 Method for increasing hydrophilicity of fluorescent label compounds |
| 04/03/2007 | US7198892 Hepatitis-C virus type 4, 5 and 6 |
| 04/03/2007 | US7198791 Immunostimulants comprising epitopes from a malarial blood-stage protein |
| 03/29/2007 | WO2007000163A8 Immobilisation of polypeptides by irradiation |
| 03/29/2007 | WO2006125140A9 Methods for treating fibrotic conditions |
| 03/29/2007 | WO2006116717A3 Autologous somatic cells from peripheral blood and uses thereof |
| 03/29/2007 | WO2006088823A3 Method for detecting misfolded proteins and prions |
| 03/29/2007 | WO2005120558A3 Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease |
| 03/29/2007 | WO2003106655A3 Fibrous protein-immobilization systems |
| 03/29/2007 | US20070073039 Peptides that inhibit viral infections |
| 03/29/2007 | DE102005046258A1 Immunosorbent for treating insulin resistance or metabolic syndrome comprises a polymeric support to which are attached ligands that specifically bind to interleukin-6 |
| 03/29/2007 | CA2623176A1 Protein a production and purification without using animal derived components |
| 03/28/2007 | EP1767640A1 Process for producing protein a-like protein with use of brevibacillus genus bacaterium |
| 03/28/2007 | EP1765362A2 Compositions and methods for treatment of neovascular diseases |
| 03/27/2007 | US7195925 Polymer having an upper critical solution temperature |
| 03/27/2007 | US7195882 Immunoglobulin for use in detection of norbuprenorphine, norbuprenorphine glucuronide and buprenorphine glucuronide in bodily fluid; drug testing for drug abuse; immunassay |
| 03/27/2007 | US7195880 DNA-protein fusions and uses thereof |
| 03/27/2007 | CA2275489C Oil bodies and associated proteins as affinity matrices |
| 03/22/2007 | US20070066798 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 03/22/2007 | US20070065887 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 03/22/2007 | US20070065873 Human T2R55 taste receptor and related assays for identifying human bitter taste modulators |
| 03/22/2007 | US20070065871 Human T2R71 receptor and related assays for identifying human bitter taste modulators |
| 03/22/2007 | US20070065870 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste |
| 03/22/2007 | US20070065407 Interferon-Alpha Polypeptides and Conjugates |
| 03/20/2007 | US7193070 Isolated DNA molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods |
| 03/20/2007 | US7193065 activated haptens useful for generating immunogens to HIV protease inhibitors |
| 03/20/2007 | US7193063 Antibodies to a polypeptide encoded by a nucleic acid overexpressed in esophageal tumor, normal stomach and melanoma |
| 03/20/2007 | US7192596 Recombinant toxin fragments |
| 03/20/2007 | US7192592 administering protein comprising a first polypeptide disulfide-bonded to a second polpeptide, wherein each of said first and second polypeptides comprises amino acid residues 258 to 370 of SEQ ID NO:2 and wherein said protein is mitogenic or chemotactic for mesenchymal cells |
| 03/20/2007 | CA2002868C Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
| 03/15/2007 | WO2007028290A1 A method for preserving human cell membrane antigen and human cell membrane antigen coated with magnetic particle |
| 03/15/2007 | WO2006117227A3 Solid phase bound thymosin alpha-1 and its synthesis |
| 03/15/2007 | WO2006015214A3 Umbilical cord stem cell composition & method of treating neurological diseases |
| 03/15/2007 | US20070061906 Human T2R75 taste receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070061905 screening mammalian chemosensory G Protein-Coupled Receptors active in taste signaling; genes and cDNA encoding such receptors |
| 03/15/2007 | US20070061904 Human T2R65 taste receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070061903 using nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners; used as additives and/or removed from foods, beverages and medicinals in order to modify (block) T2R-associated bitter taste |
| 03/15/2007 | US20070061902 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste |
| 03/15/2007 | US20070059806 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 03/15/2007 | US20070059800 Novel peptide, novel adsorbent, adsorption unit and adsorption method |
| 03/15/2007 | US20070059759 Human T2R63 receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070059723 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides |
| 03/14/2007 | CN1930461A Methods for diagnosis and pronosis of cancers of epithelial origin |
| 03/13/2007 | US7189838 PRO9834 nucleic acids |
| 03/13/2007 | US7189813 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 03/13/2007 | US7189807 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 03/08/2007 | WO2007026972A2 Binding protein molecule |
| 03/08/2007 | WO2007025388A2 Anti-apoptotic protein antibodies |
| 03/08/2007 | WO2006127712A3 Compositions and methods for inducing, stimulating and directing neuronal growth |
| 03/08/2007 | WO2006103666A3 Isolated bid polypeptides, polynucleotides encoding same and antibodies directed thereagainst and methods of using same for inducing cell cycle arrest or apoptosis |
| 03/08/2007 | WO2006076691A3 Irta-2 antibodies and their uses |
| 03/08/2007 | US20070054337 Nanoparticle conjugates and method of production thereof |
| 03/08/2007 | US20070054315 Magnetic substance-biosubstance complex structure, peptide fragment capable of linking to magnetic substance and gene therefor, and process for producing the complex structure |
| 03/08/2007 | CA2625951A1 Anti-apoptotic protein antibodies |